Influence of process conditions on drug release from pellets

International Journal of Pharmaceutics

Volumn 144, Issue 2, 1996, Pages 159-169

  Sousa, J J ^a,b   Sousa, A ^a   Podczeck, F ^b   Newton, J M ^b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Drug release; Extrusion spheronization; Pellet structure; Pellets

Indexed keywords

PROPRANOLOL;

ARTICLE; DRUG MANUFACTURE; DRUG RELEASE; DRUG SOLUBILITY; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0030606093     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04745-X     Document Type: Article

References (17)

1. Bains, D., Boutell, S.L. and Newton, J.M., The influence of moisture content on the preparation of spherical granules of barium sulphate and microcrystalline cellulose. Int. J. Pharm., 69 (1991) 233-237.
2. Bataille, B., Ligarski, K., Jacob, M., Thomas, C. and Duru, C., Study of the influence of spheronization and drying conditions on the physico-mechanical properties of neutral spheroids containing Avicel PH 101 and lactose. Drug Dev. Ind. Pharm., 19 (1993) 653-671.
3. Brockmeier, D., In vitro/in vivo correlation of dissolution using moments of dissolution and transit times. Acta Pharm. Techn., 32 (1986) 164-174.
4. Dyer, A.M., Khan, K.A. and Aulton, M.E., Effect of the drying method on the mechanical and drug release properties of pellets prepared by extrusion-spheronization. Drug Dev. Ind. Pharm., 20 (1994) 3045-3068.
5. Fielden, K.E. Newton, J.M., O'Brien, P. and Rowe, R.C., Thermal stduies on the intercation of water and microcrystalline cellulose. J. Pharm. Pharmacol., 40 (1988) 674-678.
6. Follonier, N. and Doelker, E., Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms.: STP Pharma Sci, 2 (1992) 141-158.
7. Hasznos, L. Langer, I. and Gyarmathy, M., Some factors influencing pellet characteristics made by an extrusion/ spheronization process. Part I: effects on size characteristics and moisture content decrease of pellets. Drug Dev. Ind. Phar., 18 (1992) 409-437.
8. Hileman, G.A., Goskonda, S.R., Spalitto, A.J. and Upadrashta, S.M., A factorial approach to high dose product development by an extrusion/spheronization process. Drug Dev. Ind. Pharm., 19 (1993) 483-491.
9. Kleinebudde, P., Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: I. Shrinking properties. Int. J. Pharm., 109 (1994a) 209-219.
10. Kleinebudde, P., Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: II. Swelling properties. Int. J. Pharm., 109 (1994b) 221-227.
11. Ligarski, K., Bataille, B., Jacob, M. and Cassanas, G., Influence des paramètres technologiques sur la dureté de minigranules fabriqués par extrusion/spheronization. STP Pharma Sci., 1 (1991) 256-261.
12. Lindner, H. and Kleinebudde, P., Use of powdered cellulose for the production of pellets by extrusion/spheronization. J. Pharm. Pharmacol., 46 (1994) 2-7.
13. Newton, J.M., The preparation of spherical granules by extrusion/spheronisation. STP Pharma., 6 (1990) 396-398.
14. Noché, C. Barochez, B.H., Brossard, C., Horvath, S. and Cuiné, A., Optimizing the Manufacturing Process for Controlled Release Pellets. Pharm. Techn. Eur., 4 (1994) 39-46.
15. Podczeck, F. and Newton, J.M., A shape factor to characterize the quality of spheroids. J. Pharm. Pharmacol., 46 (1994) 82-85.
16. Vervaet, C., Baert, L., Risha, P.A. and Remon, J.P., The influence of the extrusion screen on pellet quality using an instrumental basket extruder. Int. J. Pharma., 107 (1994) 29-39.
17. Voegele, D., Brockmeier, D. and Hattingberg, H.M., Modelling of input function to drug absorption by moments. In Proc. Symp Compartmental and Noncompartmental modelling in pharmaceutics, Czechoslovakia, 1988, September 12-16.